Published in Immunity on December 19, 2008
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol (2012) 3.81
Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet (2009) 3.59
Immunological mechanisms of vaccination. Nat Immunol (2011) 3.35
From vaccines to memory and back. Immunity (2010) 3.30
Variation in the human immune system is largely driven by non-heritable influences. Cell (2015) 3.07
"MIATA"-minimal information about T cell assays. Immunity (2009) 2.90
Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell (2014) 2.23
Model organisms: There's more to life than rats and flies. Nature (2012) 2.22
A genomic approach to human autoimmune diseases. Annu Rev Immunol (2010) 2.10
Why primate models matter. Am J Primatol (2014) 2.05
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog (2010) 2.03
Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A (2013) 2.00
Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci U S A (2013) 1.94
Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity (2012) 1.81
Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol (2013) 1.75
Accelerating next-generation vaccine development for global disease prevention. Science (2013) 1.73
Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci U S A (2012) 1.72
A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70
Vaccination in the elderly: an immunological perspective. Trends Immunol (2009) 1.60
Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol (2012) 1.60
Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling. Nat Rev Genet (2009) 1.59
Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med (2009) 1.54
Institutional shared resources and translational cancer research. J Transl Med (2009) 1.41
Advances in human B cell phenotypic profiling. Front Immunol (2012) 1.41
Humanizing the mouse: in defense of murine models of critical illness. Am J Respir Crit Care Med (2013) 1.36
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunol Immunother (2010) 1.36
Immune monitoring using the predictive power of immune profiles. J Immunother Cancer (2013) 1.36
Mechanisms and functions for the duration of intercellular contacts made by lymphocytes. Nat Rev Immunol (2009) 1.36
Immunological Genome Project and systems immunology. Trends Immunol (2013) 1.34
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med (2009) 1.31
Unraveling the autoimmune translational research process layer by layer. Nat Med (2012) 1.27
New insights into the regulation of human B-cell differentiation. Trends Immunol (2009) 1.26
Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans. Eur J Immunol (2012) 1.24
Primary Epstein-Barr virus infection does not erode preexisting CD8⁺ T cell memory in humans. J Exp Med (2012) 1.20
Tracing personalized health curves during infections. PLoS Biol (2011) 1.15
Dendritic cells in cancer immunotherapy clinical trials: are we making progress? Front Immunol (2013) 1.14
Autoimmunity's next top models. Nat Med (2012) 1.14
Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation. Immunity (2016) 1.12
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Front Immunol (2015) 1.12
Decreased activation of inflammatory networks during acute asthma exacerbations is associated with chronic airflow obstruction. Mucosal Immunol (2010) 1.08
Immunology taught by humans. Sci Transl Med (2012) 1.08
Transcriptional divergence and conservation of human and mouse erythropoiesis. Proc Natl Acad Sci U S A (2014) 1.05
A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur J Immunol (2011) 1.04
Translational medicine--doing it backwards. J Transl Med (2010) 1.03
Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice. Mol Ther (2010) 1.02
Translational research in immune senescence: assessing the relevance of current models. Semin Immunol (2012) 1.00
Emerging concepts in tissue-resident T cells: lessons from humans. Trends Immunol (2015) 0.99
Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc (2010) 0.97
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells. Nat Protoc (2014) 0.95
Pluripotent stem cell-derived natural killer cells for cancer therapy. Transl Res (2010) 0.93
Development and application of 'phosphoflow' as a tool for immunomonitoring. Expert Rev Vaccines (2010) 0.93
Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS One (2011) 0.93
Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci (2012) 0.93
High dimensional flow cytometry for comprehensive leukocyte immunophenotyping (CLIP) in translational research. J Immunol Methods (2010) 0.92
A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells. J Med Primatol (2010) 0.92
Restoring the balance: immunotherapeutic combinations for autoimmune disease. Dis Model Mech (2014) 0.92
Consortium biology in immunology: the perspective from the Immunological Genome Project. Nat Rev Immunol (2012) 0.92
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years. J Invest Dermatol (2014) 0.91
After GWAS: mice to the rescue? Curr Opin Immunol (2012) 0.91
No monkey business: why studying NK cells in non-human primates pays off. Front Immunol (2013) 0.91
Peroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells. Circulation (2011) 0.90
Cells in dengue virus infection in vivo. Adv Virol (2010) 0.90
Human immune responses and potential for vaccine assessment in humanized mice. Curr Opin Immunol (2013) 0.89
The human condition: an immunological perspective. Nat Immunol (2011) 0.88
Evaluation of current cancer immunotherapy: hemato-oncology. Cancer J (2011) 0.88
Barcoding of live human peripheral blood mononuclear cells for multiplexed mass cytometry. J Immunol (2015) 0.88
NLRP1 and NLRP3 inflammasomes are essential for distinct outcomes of decreased cytokines but enhanced bacterial killing upon chronic Nod2 stimulation. Am J Physiol Gastrointest Liver Physiol (2013) 0.88
Autoimmune diseases - connecting risk alleles with molecular traits of the immune system. Nat Rev Genet (2016) 0.88
Utilizing population variation, vaccination, and systems biology to study human immunology. Trends Immunol (2015) 0.88
Development of a new humanized mouse model to study acute inflammatory arthritis. J Transl Med (2012) 0.87
Screening vaccine formulations for biological activity using fresh human whole blood. Hum Vaccin Immunother (2014) 0.87
Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature. Front Endocrinol (Lausanne) (2013) 0.87
Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS One (2013) 0.86
A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev (2014) 0.86
Is human cell therapy research caught in a mousetrap? Mol Ther (2011) 0.85
Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders. Evol Med Public Health (2013) 0.85
New technologies for autoimmune disease monitoring. Curr Opin Endocrinol Diabetes Obes (2010) 0.85
Allograft outcomes in outbred mice. Am J Transplant (2013) 0.85
Human immune system variation. Nat Rev Immunol (2016) 0.84
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis. Front Immunol (2013) 0.83
Variation and genetic control of gene expression in primary immunocytes across inbred mouse strains. J Immunol (2014) 0.83
New approaches to understanding the immune response to vaccination and infection. Vaccine (2015) 0.82
New take on comparative immunology: relevance to immunotherapy. Immunotherapy (2009) 0.82
Miniaturized and high-throughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV. Clin Vaccine Immunol (2014) 0.81
Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development. Methods Mol Biol (2014) 0.81
Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity. Age (Dordr) (2013) 0.80
Stem cells and a cure for type 1 diabetes? Proc Natl Acad Sci U S A (2009) 0.80
Lymphocyte phenotypes in wild-caught rats suggest potential mechanisms underlying increased immune sensitivity in post-industrial environments. Cell Mol Immunol (2012) 0.80
Mouse models of human disease: An evolutionary perspective. Evol Med Public Health (2016) 0.79
Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine. Adv Healthc Mater (2013) 0.79
Closing the gap between genotype and phenotype. Nat Genet (2009) 0.79
Transcriptomic profiling of the development of the inflammatory response in human monocytes in vitro. PLoS One (2014) 0.79
Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis. Rheum Dis Clin North Am (2010) 0.78
Understanding and activating immunity against human cancer. Curr Opin Immunol (2010) 0.78
Investigation of the cutaneous response to recall antigen in humans in vivo. Clin Exp Immunol (2013) 0.78
Studying the human immunome: the complexity of comprehensive leukocyte immunophenotyping. Curr Top Microbiol Immunol (2014) 0.78
Ecological immunology in a fluctuating environment: an integrative analysis of tree swallow nestling immune defense. Ecol Evol (2013) 0.78
Immunological network signatures of cancer progression and survival. BMC Med Genomics (2011) 0.78
Dissecting mammalian immunity through mutation. Immunol Cell Biol (2014) 0.77
Textpresso: an ontology-based information retrieval and extraction system for biological literature. PLoS Biol (2004) 15.72
Of mice and not men: differences between mouse and human immunology. J Immunol (2004) 10.61
Systems biology and new technologies enable predictive and preventative medicine. Science (2004) 7.59
A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity (2008) 5.89
Pyogenic bacterial infections in humans with MyD88 deficiency. Science (2008) 4.92
The Human Genome Project: lessons from large-scale biology. Science (2003) 4.69
Neuroscience: Standard model. Nature (2008) 2.90
Immunotherapy: bewitched, bothered, and bewildered no more. Science (2004) 1.99
Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol (2007) 1.96
The habitual, diverse and surmountable obstacles to human immunology research. Nat Immunol (2008) 1.88
Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. J Immunol (2006) 1.79
Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity. J Exp Med (2005) 1.50
Animal models of tumor immunity, immunotherapy and cancer vaccines. Curr Opin Immunol (2004) 1.46
Microarray-based identification of novel biomarkers in IL-1-mediated diseases. Curr Opin Immunol (2007) 1.21
Expression-based Pathway Signature Analysis (EPSA): mining publicly available microarray data for insight into human disease. BMC Med Genomics (2008) 1.16
The alphabeta T cell repertoire comes into focus. Immunity (2007) 0.85